Assessment of the reporting of harms in systematic reviews focused on hallucinogens: A cross-sectional study
Harms were largely underreported in scientific literature regarding hallucinogen use, despite many studies designating them as a primary or secondary outcome. Inadequate reporting is unlikely to provide credible evidence used to evaluate the benefit-harm trade-off. Therefore, steps should be taken to improve the reporting of harms in studies concerning hallucinogen use.
Authors
- Jason Beaman (ORCID: https://orcid.org/0000-0002-6348-196X)
- Morgan Garrett (ORCID: https://orcid.org/0000-0001-5415-2200)
- Brayden Rucker (ORCID: https://orcid.org/0000-0002-4146-2776)
- Kaylin Ray
- Holly Flores (ORCID: https://orcid.org/0000-0002-5910-4600)
- Audrey Wise (ORCID: https://orcid.org/0000-0003-2353-7567)
- Micah Kee (ORCID: https://orcid.org/0000-0001-9491-2622)
- Ryan Newhardt
- Kaylyn Jade Rowsey
- Matt Vassar
- Lauren Kramer
Institutions
- Oklahoma State University Center for Health Sciences (US)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1177/02698811251399554
- Primary Topic
- Meta-analysis and systematic reviews
- Type
- article
- Field-Weighted Citation Impact
- 0.00